FengHe Fund Management
BNTX icon

FengHe Fund Management’s BioNTech BNTX Stock Holding History

FengHe Fund Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.8M Buy
+100,000
New +$9.7M 0.48% 26

Other funds holding BNTX

Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LBP AM
LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

FengHe Fund Management's BNTX Position: Q3 2026 in Review

FengHe Fund Management opened a new position in BioNTech (BNTX) in Q3 2026: 100,000 shares worth $9.8M. The stake represents 0.48% of the portfolio and ranks #26 among its holdings.

119 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • FengHe Fund Management held 100,000 shares of BioNTech worth $9.8M as of Q3 2026.
  • BioNTech was a new FengHe Fund Management position in Q3 2026.
  • BioNTech made up 0.48% of FengHe Fund Management's portfolio in Q3 2026, its #26 holding.
  • 119 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on FengHe Fund Management's 13F filing for Q3 2026, filed 2 Nov 2026.